Skip to main content
Year archive

Egetis Therapeutics — 2020 filings

All 75 regulatory filings released by Egetis Therapeutics (EGTX) in 2020, sourced directly from the official regulator.

75 Filings
2020 Period
2020 filings (75)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 English
Change in the number of shares and votes in Egetis Therapeutics
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 English
Ändring av antalet aktier och röster i Egetis Therapeutics
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 Swedish
Nomination Committee appointed for the 2021 Annual General Meeting in Egetis Therapeutics
Governance Information
2020-12-22 English
Valberedning utsedd inför årsstämman 2021 i Egetis Therapeutics
Board/Management Information
2020-12-22 Swedish
PledPharma changes its name to Egetis Therapeutics with focus on late stage orphan drug development
Regulatory Filings
2020-12-17 English
PledPharma blir Egetis Therapeutics med fokus på utveckling av särläkemedel i sen fas
Board/Management Information
2020-12-17 Swedish
Results from the prematurely closed PledOx POLAR program
Earnings Release Q2 2020
2020-12-15 English
Resultat från det i förtid avslutade POLAR programmet med PledOx
Regulatory Filings
2020-12-15 Swedish
Kommuniké från extra bolagsstämma i PledPharma AB (publ) den 11 december 2020
AGM Information
2020-12-11 Swedish
Resolutions from extraordinary general meeting in PledPharma AB (publ) held on 11 December 2020
AGM Information
2020-12-11 English
Change in the number of shares and votes in PledPharma
Declaration of Voting Results & Voting Rights Announcements
2020-11-30 English
Ändring av antalet aktier och röster i PledPharma
Share Issue/Capital Change
2020-11-30 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-27 English
PledPharma tillförs 250 MSEK genom övertecknad företrädesemission och utnyttjad övertilldelningsoption
Share Issue/Capital Change
2020-11-25 Swedish
PledPharma raises SEK 250 million in oversubscribed rights issue and utilized overallotment option
Share Issue/Capital Change
2020-11-25 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-23 English
Klargörande gällande ägarförändringar i PledPharma
Major Shareholding Notification
2020-11-23 Swedish
Clarification regarding ownership changes in PledPharma
Major Shareholding Notification
2020-11-23 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-23 Swedish
PledPharma offentliggör tilläggsprospekt
Report Publication Announcement
2020-11-12 Swedish
PledPharma publishes a supplement to the prospectus
Report Publication Announcement
2020-11-12 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-11 English
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-11 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-11 English
NOTICE TO ATTEND EXTRAORDINARY GENERAL MEETING IN PLEDPHARMA AB
AGM Information
2020-11-10 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I PLEDPHARMA AB
AGM Information
2020-11-10 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-07 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-07 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-06 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-06 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-06 Swedish
Henrik Krook appointed VP Commercial Operations at PledPharma
Board/Management Information
2020-11-06 English
Henrik Krook utsedd till VP Commercial Operations på PledPharma
Board/Management Information
2020-11-06 Swedish
PledPharma publishes prospectus and updated financial information in connection with fully guaranteed rights issue and the admission to trading of shares
Report Publication Announcement
2020-11-05 English
PledPharma offentliggör prospekt samt uppdaterad finansiell information i samband med fullt garanterad företrädesemission samt upptagande till handel av aktier
Capital/Financing Update
2020-11-05 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-03 English
Resolutions from extraordinary general meeting in PledPharma AB (publ) held on 28 October 2020
AGM Information
2020-10-28 English
Kommuniké från extra bolagsstämma i PledPharma AB (publ) den 28 oktober 2020
AGM Information
2020-10-28 Swedish
Valberedning utsedd inför årsstämman 2021 i PledPharma
Board/Management Information
2020-10-20 Swedish
Nomination Committee appointed for the 2021 Annual General Meeting in PledPharma
Board/Management Information
2020-10-20 English
Notice of Extraordinary general meeting in PledPharma AB
AGM Information
2020-10-05 Swedish
Kallelse till extra bolagsstämma i PledPharma AB
AGM Information
2020-10-05 Swedish
PledPharma carries out a fully guaranteed rights issue of approximately SEK 200 million in connection with the acquisition of Rare Thyroid Therapeutics
Capital/Financing Update
2020-10-05 English
PledPharma genomför en fullt garanterad företrädesemission om cirka 200 MSEK med anledning av förvärvet av Rare Thyroid Therapeutics
Capital/Financing Update
2020-10-05 Swedish
PledPharma ingår avtal om att förvärva Rare Thyroid Therapeutics och skapar ett bolag fokuserat på utveckling av särläkemedel
M&A Activity
2020-10-05 Swedish
PledPharma to acquire Rare Thyroid Therapeutics, creating a new focused orphan drug development company
M&A Activity
2020-10-05 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H2 2020
2020-08-20 English
Changes in PledPharma’s Board of Directors and committees
Board/Management Information
2020-07-30 English
PledPharma meddelar förändring av styrelsen och utskott
Board/Management Information
2020-07-30 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-27 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-27 Swedish
PledPharma utser Marie-Louise Alamaa som tillförordnad CFO
Board/Management Information
2020-06-24 Swedish
Marie-Louise Alamaa appointed interim CFO at PledPharma
Board/Management Information
2020-06-24 English
CFO Yilmaz Mahshid lämnar PledPharma
Board/Management Information
2020-05-26 Swedish
CFO Yilmaz Mahshid leaves PledPharma
Board/Management Information
2020-05-26 English
Kommuniké från årsstämman i PledPharma AB (publ)
AGM Information
2020-04-23 Swedish
Kommuniké från årsstämman i PledPharma AB (publ)
AGM Information
2020-04-23 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-22 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-22 English
PledPharma to close POLAR phase 3 program in the third quarter
Legal Proceedings Report
2020-04-06 English
PledPharma avslutar fas III-programmet POLAR i det tredje kvartalet
Regulatory Filings
2020-04-06 Swedish
Publicering av PledPharmas årsredovisning för 2019
Report Publication Announcement
2020-03-30 Swedish
PledPharma’s 2019 annual report published
Report Publication Announcement
2020-03-30 English
Annual Report 2019
Annual Report FY 2019
2020-03-30 Swedish
Regulatory Filings 2020
Regulatory Filings
2020-03-30 English
KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB
AGM Information
2020-03-25 English
KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB
AGM Information
2020-03-25 Swedish
PledPharma pausar dosering av patienter i POLAR programmet
Legal Proceedings Report
2020-03-01 Swedish
PledPharma places dosing of patients in the POLAR program on hold
Regulatory Filings
2020-03-01 English
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-18 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-18 English
PledPharma provides update on the clinical POLAR program, clinical hold in the US
Regulatory Filings
2020-01-23 English
PledPharma uppdaterar gällande POLAR programmet, clinical hold i USA
Regulatory Filings
2020-01-23 Swedish